ERIS.NS
Eris Lifesciences Limited [ERIS.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ERIS.NS Stock Summary
Top 10 Correlated ETFs
ERIS.NS
Top 10 Correlated Stocks
ERIS.NS
In the News
ERIS.NS Financial details
Company Rating
-
Market Cap
115.26B
Income
3.86B
Revenue
18.41B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3.55K
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
32.04
Forward P/E
-
PEG
-64.71
P/S
6.97
P/B
5.12
P/C
-
P/FCF
3961.27
Quick Ratio
1.1
Current Ratio
1.93
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
28.41
EPS next Y
-
EPS next Q
-
EPS this Y
-5.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.85%
Revenue last 5Y
11.43%
Revenue Q/Q
-3.4%
EPS Q/Q
-16.76%
-
-
-
-
SMA20
6.2%
SMA50
7.59%
SMA100
-0.41%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
33%
ROC
0.14%
Gross Margin
81%
Oper. Margin
26%
Profit Margin
22%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
597.05-971.9
52W High
+47.49%
52W Low
+139.88%
RSI
55.51
Rel Volume
0.46
Avg Volume
233.06K
Volume
107.68K
Perf Week
3.56%
Perf Month
13.18%
Perf Quarter
6.31%
Perf Half Y
11.8%
-
-
-
-
Beta
0.413
-
-
Volatility
34.01%, 63.51%
Prev Close
-2.23%
Price
1432.1
Change
-4.53%
Something similar
Company Profile
- Volume Average 233.06K
- Market Capitalization 115.26B
- Employee 3.55K
- CEO Mr. Amit Indubhushan Bakshi
- Headquarters Ahmedabad,IN
- IPO Date 2017-06-30
-
Website
https://www.eris.co.in 
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
